Pricing Log in Create free account
Friday 6 November 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

252.96 1.16 −0.46%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

STERIS plc (STE) SEC filings, changes and red flags

Red flags

No red flags have been raised by STERIS plc’s filings on file.

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 25 added · 13 removed · 58 modified
P2I1A: 7 added · 1 modified
8-K Nov 4, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Nov 4, 2026 2.02 Results of operations and financial condition; 2.05 Costs of exit or disposal activities; 9.01 Financial statements and exhibits
8-K Oct 11, 2026 1.01 Entry into a material definitive agreement
10-Q Jun 30, 2026
8-K Jul 31, 2026 5.07 Submission of matters to a vote of security holders
8-K/A May 7, 2026 5.02 Departure or appointment of directors or officers
8-K Aug 5, 2026 2.02 Results of operations and financial condition; 2.05 Costs of exit or disposal activities; 9.01 Financial statements and exhibits
10-K Mar 31, 2026 1: 1 added · 6 removed · 41 modified
1A: 11 added · 5 removed · 53 modified
7: 17 added · 21 removed · 67 modified
8-K May 11, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 1, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 31, 2026 5.02 Departure or appointment of directors or officers
10-Q Dec 31, 2025
8-K Feb 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 P1I2: 8 added · 5 removed · 43 modified
P2I1A: no changes
8-K Nov 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025 P1I2: no comparison — no earlier filing on file
P2I1A: 1 added
10-K Mar 31, 2025 1: no comparison — no earlier filing on file
1A: no comparison — no earlier filing on file
7: no comparison — no earlier filing on file

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.